Meng Li, ScM

Pharmaceutical Outcomes Research and Policy Program, University of Washington
1959 NE Pacific St. HSB
HSB-375 Box 357630
Seattle, WA
USA 98195

Papers:
HOW WELL WERE HEART FAILURE CLINICAL TRIAL ENDPOINTS SELECTED? EVIDENCE FROM A REVIEW OF CLINICALTRIALS.GOV AND OBSERVATIONAL STUDIES